Jaden was founded in late 2005 in San Diego, California by Ms. Connie Kohne and Dr. David Kohne. Ms. Kohne has more than 25 years of experience in regulatory affairs, clinical affairs, quality assurance, and quality control for the medical, biopharmaceutical, pharmaceutical and diagnostic industries. Dr. Kohne is a world-renowned expert in nucleic acid hybridization technology and has more than 40 years of experience in developing molecular diagnostic assays and methods. Dr. Kohne was the scientific founder of Gen-Probe, Inc., the first diagnostic company to receive FDA pre-market approval for a nucleic acid based molecular diagnostic assay.
In early 2008, Dr. William Soo Hoo joined Jaden as the Vice President of Assay Development. Dr. Soo Hoo is trained as an immunologist and has extensive experience in immunological techniques and assay development.
In March 2009 Jaden launched their first research diagnostic products: Ziva® Ultrasensitive BrdU Cell Proliferation Assay, Ziva® Tox Ultrasensitive Cytotoxicity Assay and Insight-Mi®, a 96-well microplate luminometer. In September 2010 Jaden was awarded a SBIR grant from the NCI/NIH to develop an ultrasensitive assay for the detection of B-cell chronic lymphocytic leukemia from a single drop of blood. In May 2011 Jaden launched their Ziva® Ultra SEAP Plus Assay.